Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 144.73%2.43M | -2.59%133.34M | -101.53%-5.44M | -16.90%136.89M | -33.57%355.68M | -31.55%164.72M | 92.90%535.43M | 360.59%240.63M | 32.85%277.58M | -65.21%52.24M |
| Operating income | 144.73%2.43M | -2.59%133.34M | -101.53%-5.44M | -16.90%136.89M | -33.57%355.68M | -31.55%164.72M | 92.90%535.43M | 360.59%240.63M | 32.85%277.58M | -65.21%52.24M |
| Cost of sales | ---- | 7.01%-108.24M | ---- | 33.81%-116.4M | 34.55%-323.42M | 26.22%-175.87M | -18.37%-494.15M | -24.48%-238.37M | -7.59%-417.47M | -5.11%-191.49M |
| Operating expenses | 7.01%-108.24M | 33.81%-116.4M | 34.55%-323.42M | 26.22%-175.87M | -18.37%-494.15M | -24.48%-238.37M | -7.59%-417.47M | -5.11%-191.49M | ||
| Gross profit | 144.73%2.43M | 22.54%25.1M | -116.85%-5.44M | 283.71%20.49M | -21.86%32.26M | -593.84%-11.15M | 129.51%41.28M | 101.62%2.26M | 21.88%-139.9M | -335.27%-139.24M |
| Selling expenses | ---- | -70.99%-18.91M | ---- | -58.79%-11.06M | 32.85%-14.93M | 19.95%-6.97M | -16.68%-22.24M | 1.13%-8.7M | 3.16%-19.06M | 17.97%-8.8M |
| Administrative expenses | -18.59%-20.3M | 10.13%-32.46M | 77.45%-17.12M | 25.28%-36.12M | -45.19%-75.92M | -0.21%-48.33M | 46.71%-52.29M | -0.03%-48.23M | 21.05%-98.11M | -47.39%-48.22M |
| Profit from asset sales | --148.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 43.11%-123.3M | ---- | 35.30%-216.74M | ---- | -36.83%-335.02M | ---- | 20.54%-244.83M | ---- | -66.21%-308.12M | ---- |
| -Other impairment is provision | 43.11%-123.3M | ---- | 35.30%-216.74M | ---- | -36.83%-335.02M | ---- | 20.54%-244.83M | ---- | -66.21%-308.12M | ---- |
| Operating interest expense | ---- | 11.41%-29.47M | ---- | -1.43%-33.27M | ---- | -3.70%-32.8M | ---- | 25.76%-31.63M | ---- | -8.48%-42.61M |
| Special items of operating profit | -1,834.02%-146.02M | 202.60%92.56M | -81.83%8.42M | 41.48%-90.22M | 688.07%46.34M | -37.89%-154.18M | 97.57%-7.88M | 36.23%-111.81M | -1,112.32%-324.62M | 40.60%-175.33M |
| Operating profit | 39.74%-139.14M | 124.52%36.83M | 33.52%-230.87M | 40.74%-150.18M | -21.44%-347.26M | -27.92%-253.43M | 67.86%-285.95M | 52.17%-198.11M | -44.82%-889.81M | -1.06%-414.19M |
| Financing cost | -139.33%-109.6M | ---- | 30.37%-45.8M | ---- | -3.95%-65.77M | ---- | 15.48%-63.27M | ---- | ---74.86M | ---- |
| Share of profits of associates | 71.11%-4.27M | -276.92%-11.43M | 51.59%-14.78M | 86.75%-3.03M | -163.48%-30.53M | -532.91%-22.89M | 581.19%48.09M | -168.85%-3.62M | -190.89%-9.99M | 61.47%-1.35M |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | 76.86%-20.66M | 32.36%-20.66M | -43.26%-89.29M | -5,874.29%-30.55M | -7,785.20%-62.33M | --529K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --55.12M |
| Earning before tax | 13.19%-253.01M | 116.57%25.39M | 37.22%-291.45M | 48.41%-153.21M | -18.90%-464.22M | -27.86%-296.98M | 62.35%-390.42M | 35.46%-232.27M | -72.09%-1.04B | 12.93%-359.89M |
| Tax | --34.52M | -6.71%-604K | ---- | 48.22%-566K | 96.86%-1.92M | -107.23%-1.09M | -972.43%-61.18M | 122.44%15.13M | 112.50%7.01M | -89.75%6.8M |
| After-tax profit from continuing operations | 25.03%-218.49M | 116.12%24.79M | 37.48%-291.45M | 48.41%-153.77M | -3.22%-466.14M | -37.26%-298.07M | 56.16%-451.59M | 38.50%-217.15M | -56.37%-1.03B | -1.75%-353.09M |
| After-tax profit from non-continuing business | 330.03%195.16M | ---- | ---84.84M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 93.80%-23.33M | 116.12%24.79M | 19.28%-376.29M | 48.41%-153.77M | -3.22%-466.14M | -37.26%-298.07M | 56.16%-451.59M | 38.50%-217.15M | -56.37%-1.03B | -1.75%-353.09M |
| Profit attributable to shareholders | 93.80%-23.33M | 116.12%24.79M | 19.28%-376.29M | 48.41%-153.77M | -3.22%-466.14M | -37.26%-298.07M | 56.16%-451.59M | 38.50%-217.15M | -56.38%-1.03B | -1.75%-353.09M |
| Basic earnings per share | 93.81%-0.0088 | 116.18%0.0094 | 25.52%-0.1421 | 56.45%-0.0581 | 6.70%-0.1908 | -35.71%-0.1334 | 56.16%-0.2045 | 38.52%-0.0983 | -56.39%-0.4665 | -1.72%-0.1599 |
| Diluted earnings per share | 93.81%-0.0088 | 116.18%0.0094 | 25.52%-0.1421 | 56.45%-0.0581 | 6.70%-0.1908 | -35.71%-0.1334 | 56.16%-0.2045 | 38.52%-0.0983 | -56.39%-0.4665 | -1.72%-0.1599 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Zhonghui Anda Certified Public Accountants Co., Ltd. | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.